Blog
Amneal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Amneal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amneal reported strong Q2 results, with revenue up 10% to $796 million, adjusted EBITDA up 12% to
Alnylam Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Alnylam Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue surged 74% to approximately $1.2 billion, driven by AMVUTTRA, which
Agios Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Agios Pharmaceuticals, Inc.? Here are five stocks we like better.
- Mitapivat revenue reached $44.7 million in Q2 2026, while Agios reported a $100.7 million net loss
Allegro MicroSystems Q1 Earnings Call Highlights
Key Points
- Interested in Allegro MicroSystems, Inc.? Here are five stocks we like better.
- Allegro reported strong fiscal Q1 results: Sales rose 27% year over year to $259 million, while non-GAAP
Symrise Q2 Earnings Call Highlights
Key Points
- Interested in Symrise AG? Here are five stocks we like better.
- Q2 momentum improved: Symrise reported €1.22 billion in second-quarter sales, with organic growth accelerating to 4.5%
Nemetschek Q2 Earnings Call Highlights
Key Points
- Interested in Nemetschek SE? Here are five stocks we like better.
- Strong first-half growth continued: Revenue increased 11.9% to €640.7 million, while recurring revenue rose 17.4% at
Drägerwerk AG & Co. KGaA Q2 Earnings Call Highlights
Key Points
- Interested in Drägerwerk AG & Co. KGaA? Here are five stocks we like better.
- Drägerwerk delivered a strong first half of 2026: sales rose 7.7% to about €1.6 billion, EBIT more than
Xerox Q2 Earnings Call Highlights
Key Points
- Interested in Xerox Holdings Co.? Here are five stocks we like better.
- Revenue rose 22% year over year to $1.92 billion in Q2 2026, driven by the Lexmark acquisition, although pro
Sanofi Q2 Earnings Call Highlights
Key Points
- Interested in Sanofi? Here are five stocks we like better.
- Sanofi raised its 2026 outlook after second-quarter sales rose 17.8% to €11.6 billion and business EPS increased 33.3%
Pharming Group Q2 Earnings Call Highlights
Key Points
- Interested in Pharming Group N.V. Sponsored ADR? Here are five stocks we like better.
- Pharming cut its 2026 outlook, forecasting revenue of $375 million to $395 million after
LKQ Q2 Earnings Call Highlights
Key Points
- Interested in LKQ Corporation? Here are five stocks we like better.
- Q2 performance weakened: Revenue fell to approximately $3.4 billion from $3.5 billion, while adjusted EPS
Neogen Q4 Earnings Call Highlights
Key Points
- Interested in Neogen Corporation? Here are five stocks we like better.
- Q4 performance improved: Neogen reported $225.3 million in revenue, with core growth accelerating to 4.3%. Food
Forbright Q2 Earnings Call Highlights
Key Points
- Interested in Forbright, Inc.? Here are five stocks we like better.
- Loan growth is expected to accelerate: Forbright’s loans rose by about $275 million sequentially, with $1.2 billion
CCC Intelligent Solutions Holdings Inc. Common Stock Q2 Earnings Call Highlights
Key Points
- Interested in CCC Intelligent Solutions Holdings Inc. Common Stock? Here are five stocks we like better.
- CCC exceeded Q2 guidance, with revenue rising 10% year over year to $286
Seplat Energy Q2 Earnings Call Highlights
Key Points
- Interested in Seplat Energy Plc? Here are five stocks we like better.
- Operational recovery drove strong first-half results: Q2 production rose 15% quarter over quarter after the
Heidelberg Materials Q2 Earnings Call Highlights
Key Points
- Interested in Heidelberg Materials AG? Here are five stocks we like better.
- Second-quarter results improved: Revenue rose 6% reported and 7% like-for-like, while operating EBITDA
Takkt Q2 Earnings Call Highlights
Key Points
- Interested in Takkt Ag? Here are five stocks we like better.
- Takkt’s business stabilized in Q2, with organic sales down 3% on a like-for-like basis excluding discontinued
The Hanover Insurance Group Q2 Earnings Call Highlights
The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across
Teva Pharmaceutical Industries Q2 Earnings Call Highlights
Teva Pharmaceutical Industries (NYSE:TEVA) reported second-quarter 2026 revenue of approximately $4.1 billion, down 1% from a year earlier in U.S. dollars
Takeda Pharmaceutical Q1 Earnings Call Highlights
Takeda Pharmaceutical (NYSE:TAK) said its first-quarter fiscal 2026 results were in line with its full-year outlook as growth from
Teladoc Health Q2 Earnings Call Highlights
Teladoc Health (NYSE:TDOC) reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected
Smurfit Westrock Q2 Earnings Call Highlights
Smurfit Westrock (NYSE:SW) reported second-quarter adjusted EBITDA of $1.14 billion and an adjusted EBITDA margin of 14.2%, as
Stanley Black & Decker Q2 Earnings Call Highlights
Stanley Black & Decker (NYSE:SWK) said second-quarter revenue was in line with the prior year and rose 3% organically, as strength
Stag Industrial Q2 Earnings Call Highlights
Stag Industrial (NYSE:STAG) said industrial real estate fundamentals continued to stabilize during the second quarter of 2026, citing stronger absorption, a
Hershey Q2 Earnings Call Highlights
Hershey (NYSE:HSY) narrowed its 2026 sales and adjusted earnings outlook to the upper half of its previous ranges after reporting stronger first-half